Last edition
News about "Port Delivery Platform"
CHMP Recommends EU Approval of Roche's Susvimo
The Committee for Medicinal Products for Human Use (CHMP) has recommended EU approval of Roche's Susvimo, the first continuous delivery treatment offering an alternative to regular eye injections for wet Age-related Macular Degeneration (AMD).
Port Delivery Platform | 25/07/2026 | By News Bureau
Roche Deploys Contivue Manufacturing Platform with CE Mark for nAMD Continuous Drug Delivery
Roche has received CE marking in the European Union for Contivue, its innovative Port Delivery Platform for administering Susvimo in the treatment of neovascular (wet) age-related macular degeneration (nAMD).
Port Delivery Platform | 04/09/2025 | By Darshana | 337
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy